Galectin Therapeutics Inc. (GALT)

Galectin Therapeutics Statistics

Total Valuation

GALT has a market cap or net worth of $144.16 million. The enterprise value is $264.16 million.

Market Cap	144.16M
Enterprise Value	264.16M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026, before market open.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

GALT has 65.83 million shares outstanding. The number of shares has increased by 2.56% in one year.

Current Share Class	65.83M
Shares Outstanding	65.83M
Shares Change (YoY)	+2.56%
Shares Change (QoQ)	+0.84%
Owned by Insiders (%)	19.83%
Owned by Institutions (%)	18.04%
Float	47.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.42

Current Ratio	2.42
Quick Ratio	2.21
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.74

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-67.81%
Return on Invested Capital (ROIC)	-166.10%
Return on Capital Employed (ROCE)	-174.62%
Weighted Average Cost of Capital (WACC)	7.14%
Revenue Per Employee	n/a
Profits Per Employee	-$2.06M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +65.91% in the last 52 weeks. The beta is 1.04, so GALT's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	+65.91%
50-Day Moving Average	2.92
200-Day Moving Average	3.95
Relative Strength Index (RSI)	30.83
Average Volume (20 Days)	364,506

Short Selling Information

The latest short interest is 6.57 million, so 9.98% of the outstanding shares have been sold short.

Short Interest	6.57M
Short Previous Month	5.17M
Short % of Shares Out	9.98%
Short % of Float	13.93%
Short Ratio (days to cover)	21.45

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-20.09M
Pretax Income	-30.84M
Net Income	-30.97M
EBITDA	n/a
EBIT	-20.09M
Earnings Per Share (EPS)	-$0.48

Balance Sheet

The company has $17.72 million in cash and $137.72 million in debt, with a net cash position of -$120.00 million or -$1.82 per share.

Cash & Cash Equivalents	17.72M
Total Debt	137.72M
Net Cash	-120.00M
Net Cash Per Share	-$1.82
Equity (Book Value)	-126.20M
Book Value Per Share	-1.97
Working Capital	11.41M

Cash Flow

Operating Cash Flow	-23.88M
Capital Expenditures	n/a
Depreciation & Amortization	53,000
Net Borrowing	21.00M
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GALT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.56%
Shareholder Yield	-2.56%
Earnings Yield	-21.49%
FCF Yield	n/a

Analyst Forecast

The average price target for GALT is $8.50, which is 288.13% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.50
Price Target Difference	288.13%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 23, 2012. It was a reverse split with a ratio of 1:6.

Last Split Date	Mar 23, 2012
Split Type	Reverse
Split Ratio	1:6

Scores

Altman Z-Score	n/a
Piotroski F-Score	1